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Abstract: 
Triple-negative breast cancer (TNBC) is characterized by its higher incidence of recurrence and 
more aggressive clinical course. Due to higher rate of recurrence, early detection is urgently 
needed as well as an effective delivery of anticancer drug to tumor sites to increase patient 
survival. In this study, we develop theranostic nanoparticles loaded with anticancer drug 
(docetaxel) and diagnostic agent (iron oxide) to achieve simultaneous effect of therapeutic and 
diagnostic. Vitamin E TPGS was used as the nanocarriers, it has amphiphilic structure which is 
useful in the preparation of nanoparticles to encapsulate hydrophobic drug. This docetaxel-iron 
oxide loaded TPGS micelles were synthesized using solvent casting method. These micelles 
were characterized for its nanoparticles properties such as size, surface charge, morphology 
and drug loading. The synthesized micelles size found to be between the range of 15nm and 
100nm for single drug and dual drug loading respectively. These micelles have uniform size 
distribution with polydispersity index less than 0.3. The surface charged of the micelles is 
negative between -7 mV and -20 mV. Whereas, the micelles have smooth spherical shape as 
observed under cryo-TEM. Overall, our micelles have higher drug loading which is suitable to 
use for effective delivery for triple negative breast cancer treatment.  
 
 
 
Keywords :  Dual Drug Delivery; Biomaterial; Nanomedicine; Pharmaceutical; Cancer 
 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGMENT 
 
 
The authors like to thank Ministry of Education Malaysia for supporting the project throught 
FRGS (RDU170130). 
